Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NUE vs GSK✓SelectedUSD · GSKNUE vs GSK performance historyLatest closeAs of+0.37%11/16
Stock and ETF performance explorer

NUE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+13,886.7%
GSK return
+1,741.1%
Excess return
+12,145.6%
Maximum drawdown
-68.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.4%-0.1%+0.5%+0.4%
7D+1.4%-1.3%+2.7%+1.8%
30D-1.4%+2.7%-4.1%-2.6%
3M-5.8%+2.7%-8.5%-7.2%
6M+11.8%+3.3%+8.5%+9.8%
YTD+56.2%+6.5%+49.7%+51.0%
1Y+73.0%+10.7%+62.3%+64.9%
3Y+70.1%+64.4%+5.7%+36.4%
5Y+143.3%+46.7%+96.6%+100.8%
10Y+421.8%+109.4%+312.4%+275.0%
All+13,886.7%+1,741.1%+12,145.6%+4,779.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling